Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

22.07
Delayed Data
As of Jan 12
 +0.33 / +1.52%
Today’s Change
10.85
Today|||52-Week Range
37.94
+16.46%
Year-to-Date
Parkinson's Disease Space Again Under Spotlight This Week
Jan 11 / Zacks.com - Paid Partner Content
Momenta Reports Positive Top-Line Data on Antibody M281
Jan 09 / Zacks.com - Paid Partner Content
AstraZeneca's Asthma Drug Benralizumab Gets Approval in EU
Jan 11 / Zacks.com - Paid Partner Content
Momenta & Mylan to Initiate Trial on Biosimilar of Eylea
Jan 04 / Zacks.com - Paid Partner Content